home / stock / snynf / snynf message board
Subject | By | Source | When |
---|---|---|---|
whytestocks: $SNYNF News Article - Press Release: Sanofi completes acquisition of Provention Bio, In | whytestocks | investorshangout | 04/27/2023 12:55:46 PM |
whytestocks: $SNYNF News Article - Press Release: Nirsevimab: Sanofi, AstraZeneca and Sobi simplify | whytestocks | investorshangout | 04/11/2023 12:25:46 PM |
chartguy89: SNYNF 105.0981 Stock Charts $SNYNF 1 Month Chart | chartguy89 | investorshangout | 03/10/2014 2:57:13 AM |
chartguy89: SNYNF Stock Charts Last: +1.85 Saturday, March 1, 2014 at 5:47:25 PM $SNYNF 1 Mo | chartguy89 | investorshangout | 03/01/2014 10:47:37 PM |
News, Short Squeeze, Breakout and More Instantly...
Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant RSV hospitalizations New real-world evidence shows Beyfortus (nirsevimab) substantially reduced RSV lower respiratory tract disease and hospitalizations in infants during the 2023-2024 RSV season, versus n...
Annual General Meeting of April 30, 2024 Approval of the financial statements for the fiscal year 2023 Distribution of a cash dividend of €3.76 per share, with payment as of May 15, 2024 Board composition: renewal of two Directors and appointment of three new Independent Di...
Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance Paris, April 25, 2024 Sales growth of 6.7% at CER and business EPS (1) of €1.78 Dupixent sales up 24.9% to €2,835 million, on target to deliver ~€...